3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma NVRS

Noveris Health Sciences Inc.

NVRS CSE Biotech & Pharma

Stock factsheet

TickerNVRS
ExchangeCSE
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 44 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Noveris Health Sciences Inc. is a biotechnology company focused on the development, advancement, and commercialization of intellectual property, technologies, and therapeutic opportunities addressing significant unmet needs in healthcare. The Company continues to evaluate opportunities to create value through strategic partnerships, licensing arrangements, research collaborations, and related commercial initiatives.

Company description as published by the issuer via Canadian Securities Exchange.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Noveris Health Sciences Inc.NVRS CSE44 Mio. USD
Covalon Technologies Ltd. COVTSXV 44 Mio. USD
Ocumetics Technology Corp. OTCTSXV 43 Mio. USD
BioMark Diagnostics Inc. BUXCSE 43 Mio. USD
Eastwood Bio-Medical Canada Inc. EBMTSXV 48 Mio. USD
Arch Biopartners Inc. ARCHTSXV 39 Mio. USD
Planet 13 Holdings Inc. PLTHCSE 38 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.